Vascular injury in macroscopically normal skin of patients with severe COVID-19 infection: clinical-pathologic correlations

1. https://coronavirus.jhu.edu/map.html Search in Google Scholar

2. Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr. 2020;14(4):407-412. doi:10.1016/j.dsx.2020.04.02010.1016/j.dsx.2020.04.020716510832335367 Search in Google Scholar

3. Criado PR, Abdalla BMZ, de Assis IC, van Blarcum de Graaff Mello C, Caputo GC, Vieira IC. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020;69(8):745-756. doi:10.1007/s00011-020-01370-w10.1007/s00011-020-01370-w726638732488318 Search in Google Scholar

4. Gao Z, Xu Y, Sun C, et al. A Systematic Review of Asymptomatic Infections with COVID-19 [published online ahead of print, 2020 May 15]. J Microbiol Immunol Infect. 2020;10.1016/j.jmii.2020.05.001 doi. org/10.1016/j.jmii.2020.05.001 Search in Google Scholar

5. Chen Y, Wang AH, Yi B, Ding KQ, Wang HB, Wang JM, et al. The epidemiological characteristics of infection in close contacts of COVID-19 in Ningbo city[J/OL]. Chin J Epidemiol 2020:41. https://doi.org/10.3760/cma.j.cn112338-20200304-00251 Search in Google Scholar

6. Machhi J, Herskovitz J, Senan AM, et al. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections [published online ahead of print, 2020 Jul 21]. J Neuroimmune Pharmacol. 2020;1-28. doi:10.1007/s11481-020-09944-510.1007/s11481-020-09944-5737333932696264 Search in Google Scholar

7. Shurin MR, Morris A, Wells A, Wheeler SE. Assessing Immune Response to SARS-CoV-2 Infection. Immunotargets Ther. 2020;9:111-114. Published 2020 Jun 11. doi:10.2147/ITT.S26413810.2147/ITT.S264138729545532607314 Search in Google Scholar

8. Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020;108(1):17-41. doi:10.1002/JLB.3COVR0520-272R10.1002/JLB.3COVR0520-272R732325032534467 Search in Google Scholar

9. Jamilloux Y, Henry T, Belot A, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020;19(7):102567. doi:10.1016/j. autrev.2020.102567. Search in Google Scholar

10. Carter-Timofte ME, Jørgensen SE, Freytag MR, et al. Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19. Front Immunol. 2020;11:1606. Published 2020 Jun 30. doi:10.3389/fimmu.2020.0160610.3389/fimmu.2020.01606733858832695122 Search in Google Scholar

11. Marietta, M., Coluccio, V. & Luppi, M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med (2020). https://doi.org/10.1007/s11739-020-02432-x10.1007/s11739-020-02432-x735208732653981 Search in Google Scholar

12. Ghazal, S., Litvinov, I. V., Aljahani, N., Jfri, A., & Netchiporouk, E. (2020). Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection—What Do We Know So Far? Journal of Cutaneous Medicine and Surgery, 24(4), 416–417. https://doi.org/10.1177/120347542092837510.1177/120347542092837532391713 Search in Google Scholar

13. Kaya, Gürkan & Kaya, Aysin & Saurat, Jean-Hilaire. (2020). Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature. Dermatopathology. 7. 3-16. 10.3390/dermatopathology7010002.10.3390/dermatopathology7010002758359332608380 Search in Google Scholar

14. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.1916310.1111/bjd.19163726723632348545 Search in Google Scholar

15. WHO Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. 2020.https://www.who.int/publications-etail/clinicalmanagement-of-severe-acute-respiratory-infection-whennovel-coronavirus-(ncov)-infection-is-suspected Search in Google Scholar

16. Zaki N, Alashwal H, Ibrahim S. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review [published online ahead of print, 2020 Jul 8]. Diabetes Metab Syndr. 2020;14(5):1133-1142. doi:10.1016/j.dsx.2020.07.00510.1016/j.dsx.2020.07.005 Search in Google Scholar

17. Tobaiqy M, Qashqary M, Al-Dahery S, et al. Therapeutic management of patients with COVID-19: a systematic review. Infection Prevention in Practice. 2020;2(3):100061. doi:10.1016/j.infpip.2020.10006110.1016/j.infpip.2020.100061 Search in Google Scholar

18. Warkentin TE, Kaatz S. COVID-19 versus HIT hypercoagulability [published online ahead of print, 2020 Aug 10]. Thromb Res. 2020;196:38-51. doi:10.1016/j.thromres.2020.08.01710.1016/j.thromres.2020.08.017 Search in Google Scholar

19. Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9-14. doi:10.1016/j.thromres.2020.04.02410.1016/j.thromres.2020.04.024 Search in Google Scholar

20. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1-13. doi:10.1016/j.trsl.2020.04.00710.1016/j.trsl.2020.04.007 Search in Google Scholar

21. Pons, Stéphanie & Fodil, Sofiane & Azoulay, Elie & Zafrani, Lara. (2020). The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Critical Care. 24. 10.1186/s13054-020-03062-7.10.1186/s13054-020-03062-7 Search in Google Scholar

22. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418. doi:10.1016/S0140-6736(20)30937-510.1016/S0140-6736(20)30937-5 Search in Google Scholar

23. Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219-227. doi:10.1016/j.kint.2020.04.003.10.1016/j.kint.2020.04.003 Search in Google Scholar

24. Copin MC, Parmentier E, Duburcq T, Poissy J, Mathieu D; Lille COVID-19 ICU and Anatomopathology Group. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med. 2020;46(6):1124-1126. doi:10.1007/s00134-020-06057-810.1007/s00134-020-06057-8 Search in Google Scholar

25. Bradley BT, Maioli H, Johnston R, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet (London, England). 2020 Aug;396(10247):320-332. DOI: 10.1016/s0140-6736(20)31305-2.10.1016/S0140-6736(20)31305-2 Search in Google Scholar

26. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-2040. doi:10.1182/blood.202000600010.1182/blood.2020006000727382732339221 Search in Google Scholar

27. Marietta, M., Coluccio, V. & Luppi, M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med (2020). https://doi.org/10.1007/s11739-020-02432-x10.1007/s11739-020-02432-x735208732653981 Search in Google Scholar

28. Warkentin TE, Kaatz S. COVID-19 versus HIT hypercoagulability [published online ahead of print, 2020 Aug 10]. Thromb Res. 2020;196:38-51. doi:10.1016/j.thromres.2020.08.01710.1016/j.thromres.2020.08.017741671732841919 Search in Google Scholar

29. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published correction appears in Intensive Care Med. 2020 Apr 6;:]. Intensive Care Med. 2020;46(5):846-848. doi:10.1007/s00134-020-05991-x10.1007/s00134-020-05991-x708011632125452 Search in Google Scholar

30. Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020;44(9):1792-1797. doi:10.1002/cbin.1140310.1002/cbin.11403728367232458561 Search in Google Scholar

31. Thevarajan I, Nguyen THO, Koutsakos M, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nature Medicine. 2020 Apr;26(4):453-455. DOI: 10.1038/s41591-020-0819-2.10.1038/s41591-020-0819-2709503632284614 Search in Google Scholar

32. Cecconi M, Piovani D, Brunetta E, et al. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy. J Clin Med. 2020;9(5):1548. Published 2020 May 20. doi:10.3390/jcm905154810.3390/jcm9051548729083332443899 Search in Google Scholar

33. Zhang JJ, Cao YY, Tan G, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients [published online ahead of print, 2020 Jul 14]. Allergy. 2020;10.1111/all.14496. doi:10.1111/all.1449610.1111/all.14496740475232662525 Search in Google Scholar

34. Herold T, Jurinovic V, Arnreich C, et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146(1):128-136.e4. doi:10.1016/j.jaci.2020.05.00810.1016/j.jaci.2020.05.008723323932425269 Search in Google Scholar

35. Low SpO2: oxygen saturation below 95 %; Hb: haemoglobin; WBC: white blood cell count; CRP:c-reactive protein; PCT: procalcitonin; COPD: chronic obstructive pulmonary disease; CK-MB: creatine kinase isoensyme MB; # during evolution Search in Google Scholar